By proceeding, you agree to our Terms of Use and Privacy Policy.
CEO and Founder
#Harnessingpublicly #transcriptomedata
#Europe
At Shift Bioscience, Daniel is making drugs for safe cellular rejuvenation and mitigation of age-linked diseases through the application of machine-learning to cellular reprogramming.